Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A recent Japanese study found that this risk reduction was greater than that associated with the hep B vaccine.
This PrEP dosing strategy involves taking doses of Truvada only during the days surrounding sex.
The assurance arrives as the pharma giant cuts off most emergency access to remdesivir, a potential COVID-19 treatment.
The country’s National Health Service will pay for the drug as part of its goal to end HIV transmission by 2030.
Researchers are looking for ways to reduce the doses needed for on-demand PrEP and the 30-day duration recommended for PEP.
This may not lower PrEP’s efficacy, but very strict adherence to the daily Truvada regimen is key for pregnant women.
More than 230,000 women and girls have been diagnosed with HIV in the United States; this year’s theme focuses on prevention.
The U.S. PEPFAR program analyzed PrEP scale-up patterns and found that growth was greater among cisgender heterosexuals.
Attendees will hear news about the second probable HIV cure, long-acting injectable meds and COVID-19.
In a recent small study, resistance was limited to the emtricitabine component of Truvada and did not seem a major cause for concern.
Under the bill, intentionally transmitting HIV to a sexual partner is reduced from a felony to a misdemeanor. And that’s not all.
From the new coronavirus to “unsafe” sex, Bob Leahy writes about how we all process risk differently and why that’s OK.
Misleading ads about Truvada as PrEP continue to impede HIV prevention.
This is especially the case for people globally who don’t have access to such newer regimens.
Researchers examined increasing use of PrEP, expanding access to opioid use disorder treatment and improving engagement with HIV care.
The International AIDS Conference takes place July 6 to 10 in San Francisco and Oakland.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.